Researchers frequently face ethical decisions in clinical trials. This text focuses on whether to halt or continue a study when interim data (data before end of trial) (Wikipedia contributors) indicate that continuing may put patients at risk. In a new drug trial, participants are divided into a control group (receiving no or standard treatment) and an experimental group (receiving the new treatment). I will argue using the ethical frameworks of Deontology and Teleology as well as research to back up each argument, that it is not ethical to prematurely end clinical trial if the drugs appear…